BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7273379)

  • 21. Myocardial depression after elective ischemic arrest. Subcellular biochemistry and prevention.
    Gillette PC; Pinsky WW; Lewis RM; Bornet EP; Wood JM; Entman ML; Schwartz A
    J Thorac Cardiovasc Surg; 1979 Apr; 77(4):608-18. PubMed ID: 423595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Protective effects of lidoflazine and mioflazine in ischemic myocardium].
    Liu GS; Borgers M; Xhonneux R
    Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Apr; 16(2):100-2, 127. PubMed ID: 3197595
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term morphologic and hemodynamic evaluation of the left ventricle after cardiopulmonary bypass. A comparison of normothermic anoxic arrest, coronary artery perfusion, and profound topical cardiac hypothermia.
    Brody WR; Reitz BA; Andrews MJ; Roberts WC; Michaelis LL
    J Thorac Cardiovasc Surg; 1975 Dec; 70(6):1073-87. PubMed ID: 1186284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of prolonged lidoflazine (R 7904) treatment on resting ECG, heart rate and blood pressure. A retrospective study.
    Bosmans P; Reinards J; Terrijn R; Vandervoort R
    Acta Cardiol; 1977; 32(2):87-97. PubMed ID: 302077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of lidoflazine on ventricular ectopic activity in chronic ischaemic heart disease.
    Myburgh DP
    S Afr Med J; 1975 Nov; 49(50):2087-90. PubMed ID: 1198246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ischemic changes in the canine heart as affected by the dimethyl quaternary analog of propranolol, UM-272 (SC-27761).
    Lucchesi BR; Burmeister WE; Lomas TE; Abrams GD
    J Pharmacol Exp Ther; 1976 Nov; 199(2):310-28. PubMed ID: 978488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on prolonged acute regional ischemia. IV. Aggressive surgical treatment for intractable ventricular fibrillation after acute myocardial infarction.
    Beyersdorf F; Acar C; Buckberg GD; Partington MT; Okamoto F; Allen BS; Bugyi HI; Young HH
    J Thorac Cardiovasc Surg; 1989 Oct; 98(4):557-66. PubMed ID: 2796363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological preservation of the ischemic heart.
    Clark RE; Ferguson TB; West PN; Shuchleib RC; Henry PD
    Ann Thorac Surg; 1977 Oct; 24(4):307-14. PubMed ID: 907399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of ischemic damage with amino acid substrate enhancement during reperfusion.
    Lazar HL; Buckberg GD; Manganaro AJ; Becker H; Maloney JV
    Surgery; 1980 Nov; 88(5):702-9. PubMed ID: 7434210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of systemic hypertension on ischemic and nonischemic regional left ventricular function in awake, unsedated dogs after experimental coronary occlusion.
    Roan PG; Buja M; Saffer S; Izquierdo C; Hagler H; Duke B; Hillis LD; Willerson JT
    Circulation; 1982 Jan; 65(1):115-25. PubMed ID: 6796286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electromechanical dissociation after ventricular fibrillation: prevention with calcium-entry blockers.
    Vincent JL; Goldstein J; Dufaye P; Domb M
    J Cardiovasc Pharmacol; 1984; 6(6):1124-31. PubMed ID: 6084770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inability of flunarizine, lidoflazine or magnesium to counteract delayed hypoperfusion after forebrain ischaemia in the rat.
    Grøgaard B; Gerdin B; Arfors KE
    Acta Neurochir (Wien); 1988; 95(3-4):136-42. PubMed ID: 3228003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of diltiazem and propranolol on left ventricular segmental relaxation during temporary coronary arterial occlusion and one month reperfusion in conscious dogs.
    Tilton GD; Bush LR; Apprill PG; Buja LM; Willerson JT
    Circulation; 1985 Jan; 71(1):165-75. PubMed ID: 3964719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of molsidomin on left ventricular function and volume in patients with coronary heart disease (author's transl)].
    Karsch KR; Blanke H; Kreuzer H; Rentrop KP
    Z Kardiol; 1979 Feb; 68(2):71-6. PubMed ID: 425616
    [No Abstract]   [Full Text] [Related]  

  • 35. Reduction of ischemic myocardial damage in the dog by lidocaine infusion.
    Schaub RG; Stewart G; Strong M; Ruotolo R; Lemoie G
    Am J Pathol; 1977 May; 87(2):399-414. PubMed ID: 851172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations in energy metabolism and ultrastructure upon reperfusion of the ischemic myocardium after coronary occlusion.
    Puri PS; Varley KG; Kim SW; Barwinsky J; Cohen M; Dhalla NS
    Am J Cardiol; 1975 Aug; 36(2):234-43. PubMed ID: 1080352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left ventricular dysfunction and disturbed O(2)-utilization in stunned myocardium: influence of ischemic preconditioning.
    Sunderdiek U; Schmitz-Spanke S; Korbmacher B; Gams E; Schipke JD
    Eur J Cardiothorac Surg; 2001 Oct; 20(4):770-6. PubMed ID: 11574223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of lidoflazine on cerebral blood flow following twelve minutes total cerebral ischemia.
    Dean JM; Hoehner PJ; Rogers MC; Traystman RJ
    Stroke; 1984; 15(3):531-5. PubMed ID: 6427983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detrimental effects of premature use of inotropic drugs to discontinue cardiopulmonary bypass.
    Lazar HL; Buckberg GD; Foglia RP; Manganaro AJ; Maloney JV
    J Thorac Cardiovasc Surg; 1981 Jul; 82(1):18-25. PubMed ID: 7242127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of left heart bypass on cardiac performance following myocardial ischemia.
    Scherf C; Turina M; Senning A
    J Cardiovasc Surg (Torino); 1975; 16(3):278-82. PubMed ID: 1150733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.